Sartorius AG (XSWX:SRT3) Other Current Assets: CHF175 Mil (As of Mar. 2026)


XSWX:SRT3 Sartorius AG XSWX:SRT3
82 GF Score
Price CHF207.80
GF Value CHF228.12
! 9 Warning Signs
View Full Analysis

What is Sartorius AG Other Current Assets?

Sartorius AG XSWX:SRT3 +0.29% 82 Other Current Assets is CHF175 Mil as of Mar. 2026. GuruFocus rates XSWX:SRT3 with a GF Score™ of 82/100 and a GF Value™ of CHF228.12. The stock has 9 warning signs investors should review.

Sartorius AG's other current assets for the quarter that ended in Mar. 2026 was CHF175 Mil.

Sartorius AG's quarterly other current assets declined from Sep. 2025 (CHF169 Mil) to Dec. 2025 (CHF169 Mil) but then increased from Dec. 2025 (CHF169 Mil) to Mar. 2026 (CHF175Mil).

Sartorius AG's annual other current assets increased from Dec. 2023 (CHF152 Mil) to Dec. 2024 (CHF157 Mil) increased from Dec. 2024 (CHF157 Mil) to Dec. 2025 (CHF169 Mil).


Sartorius AG Other Current Assets Related Terms


Sartorius AG Other Current Assets Historical Data

* Premium members only.

The historical data trend for Sartorius AG's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG Other Current Assets Chart

Sartorius AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118.43 152.47 151.65 156.66 168.81

Sartorius AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 164.30 172.96 169.31 168.81 175.30
XSWX:SRT3
82GF Score
Sartorius AG XSWX:SRT3
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius AG Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of CHF175 Mil mean?
Sartorius AG (XSWX:SRT3) has a Other Current Assets of CHF175 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Sartorius AG.
Is Sartorius AG's Other Current Assets too high?
Sartorius AG's current Other Current Assets is CHF175 Mil. Overall, Sartorius AG has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's Other Current Assets compare to ISRG and BDX?
Sartorius AG's Other Current Assets of CHF175 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Medical Devices & Instruments company?
A good Other Current Assets depends on the Medical Devices & Instruments industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Sartorius AG. Sartorius AG's current Other Current Assets is CHF175 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Sartorius AG (XSWX:SRT3) has a current Other Current Assets of CHF175 Mil. The stock's GF Value™ is CHF228.12, compared to a current price of CHF207.80 — trading 8.9% below its estimated fair value. The current Other Current Assets is CHF175 Mil. Sartorius AG's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Sartorius AG (XSWX:SRT3), the current Other Current Assets is CHF175 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius AG (XSWX:SRT3) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued. The current stock price of CHF207.80 is trading 8.9% below its estimated GF Value™ of CHF228.12.

Key valuation signals for XSWX:SRT3:

  • Other Current Assets: CHF175 Mil
  • GF Value™: CHF228.12 vs. price of CHF207.80 (8.9% below fair value)
  • GF Score™: 82/100 with 9 warning signs

No single metric tells the full story. See the XSWX:SRT3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius AG Business Description

Address Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
82GF Score

Get the complete analysis for XSWX:SRT3

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF207.80
Price
CHF228.12
GF Value